Mark Newman - 01 Mar 2023 Form 4 Insider Report for Chemours Co (CC)

Role
President and CEO, Director
Signature
/s/ Pauletta Brown, Attorney-in-Fact
Issuer symbol
CC
Transactions as of
01 Mar 2023
Transactions value $
-$182,840
Form type
4
Filing time
03 Mar 2023, 20:09:47 UTC
Previous filing
14 Feb 2023
Next filing
12 Jun 2023
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CC Common Stock Tax liability -$183K -5.25K -2.37% $34.84 216K 01 Mar 2023 Direct F1, F2
transaction CC Common Stock Award $0 +43.1K +19.92% $0.00 259K 01 Mar 2023 Direct F2, F3
holding CC Common Stock 2.48K 01 Mar 2023 Reporting person's children
holding CC Common Stock 32.2K 01 Mar 2023 By GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CC Stock Option (Right to Buy) Award $0 +97.7K $0.00 97.7K 01 Mar 2023 Common Stock 97.7K $34.84 Direct F4
transaction CC Performance Stock Option (Right to Buy) Award $0 +96.3K $0.00 96.3K 01 Mar 2023 Common Stock 96.3K $38.32 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024.
F2 Includes directly owned shares, restricted stock units and dividend equivalent units.
F3 Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
F4 These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.
F5 Represents a 10 percent premium above the closing price of the Company common stock on the date of grant